Comparison [acty]
Continuous [idcn]
Sequential [idcn]
Transdermal [ftcn]
Progestagen [horm, phsu, strd]
Sequential [idcn]
Oral [spco]
Progestagen [horm, phsu, strd]
postmenopausal [tmco]
Women [popg]
Continuous [idcn]
transdermal estrogen [horm, phsu, strd]
vasomotor symptom [sosy]
Bleeding [patf]
Patterns [spco]
Lipids [lipd]
Objective [inpr]
Efficacy [qlco]
Bleeding [patf]
Patterns [spco]
Safety [hcpp]
Continuous [idcn]
Transdermal [ftcn]
Sequential [idcn]
Transdermal [ftcn]
Progestagen [horm, phsu, strd]
therapy [ftcn]
Compared [acty]
Oral [spco]
Progestagen [horm, phsu, strd]
therapy [ftcn]
postmenopausal [tmco]
Women [popg]
Receive [qlco]
transdermal estrogen [horm, phsu, strd]
Methods [inpr]
OPEN LABEL [resa]
treatment [ftcn]
days [tmco]
randomized [resa]
Study [mnob]
postmenopausal [tmco]
Women [popg]
Assigned [ftcn]
Receive [qlco]
MU/day [qnco]
Continuous [idcn]
Transdermal [ftcn]
Estradiol [horm, phsu, strd]
Continuous [idcn]
Sequential [idcn]
Transdermal [ftcn]
Norethisterone acetate [horm, phsu, strd]
Daily Dose [qnco]
mU/g [qnco]
Single patch [medd]
Transdermal [ftcn]
Sequential [idcn]
Oral [spco]
Progestagen [horm, phsu, strd]
mg% [qnco]
Norethisterone [horm, phsu, strd]
mg day [qnco]
Dydrogesterone [horm, phsu, strd]
Average [qnco]
Hot flushes [sosy]
Decreased [qnco]
Over [spco]
>90 [qnco]
P NOS [aapp, imft]
reduction [npop]
Unaffected [cnce]
Progestagen [horm, phsu, strd]
regimens [inpr]
Sequential [idcn]
Progestagen [horm, phsu, strd]
Bleeding [patf]
Bleeding [patf]
days [tmco]
Course [tmco]
Study [mnob]
Low dose [qnco]
Transdermal [ftcn]
Progestagen [horm, phsu, strd]
Group [idcn]
Continuous [idcn]
Progestagen [horm, phsu, strd]
Bleeding [patf]
Decreased [qnco]
High dose [qnco]
Group [idcn]
treatment [ftcn]
End [spco]
treatment [ftcn]
Adverse event [fndg]
Group [idcn]
Subject [grup]
Reporting [hlca]
Events [evnt]
Possibly [qlco]
Probably [idcn]
HRT [topp]
Exclude [ftcn]
Vaginal Bleeding [patf]
Cases [ftcn]
Simple [qlco]
Hyperplasia [patf]
Reported [inpr]
Dose [qnco]
Progestagen [horm, phsu, strd]
Group [idcn]
effects [qlco]
Coronary heart disease risk [inpr]
reductions [npop]
Total Cholesterol [lbpr]
Low Density Lipoprotein Cholesterol [bacs, strd]
High density lipoprotein cholesterol level [lbpr]
Measured [qlco]
treatment [ftcn]
Group [idcn]
Lipoprotein (a) [aapp, bacs]
Reduced [qlco]
Oral [spco]
Progestagen [horm, phsu, strd]
Group [idcn]
Conclusions [idcn]
Continuous [idcn]
Sequential Treatment [topp]
transdermal estrogen [horm, phsu, strd]
Progestagen [horm, phsu, strd]
Estradiol + norethindrone acetate [horm, phsu, strd]
APPEAR [qlco]
effective [qlco]
Alternative [cnce]
Continuous [idcn]
transdermal estrogen [horm, phsu, strd]
Oral [spco]
Sequential [idcn]
Progestagen [horm, phsu, strd]
treatment [ftcn]
menopausal symptoms [sosy]
Continuous [idcn]
Transdermal [ftcn]
therapy [ftcn]
Estradiol + norethindrone acetate [horm, phsu, strd]
Acceptable [qlco]
majority [socb]
Patients [podg]
i e [diap, inpr]
WISH [gngm]
Monthly [tmco]
bleed [patf]
Sequential [idcn]
Regimen [topp]
Clinician [prog]
Monthly [tmco]
Bleeding [patf]
Appropriate [qlco]
